GLABF (Gemina Laboratories) LT-Debt-to-Total-Asset: 0.00 (As of Oct. 2025)


What is Gemina Laboratories LT-Debt-to-Total-Asset?

Gemina Laboratories GLABF -27.59% LT-Debt-to-Total-Asset is 0.00 as of Oct. 2025. The stock has 2 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Gemina Laboratories's long-term debt to total assests ratio for the quarter that ended in Oct. 2025 was 0.00.

Gemina Laboratories's long-term debt to total assets ratio declined from Oct. 2024 (0.13) to Oct. 2025 (0.00). It may suggest that Gemina Laboratories is progressively becoming less dependent on debt to grow their business.

Gemina Laboratories  (OTCPK:GLABF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Gemina Laboratories LT-Debt-to-Total-Asset Related Terms

Gemina Laboratories LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories LT-Debt-to-Total-Asset Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
LT-Debt-to-Total-Asset
0.02 0.00 0.11 0.14 0.12

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.12 0.00 0.00 0.00

Gemina Laboratories LT-Debt-to-Total-Asset Calculation

Gemina Laboratories's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jan. 2025 is calculated as

LT Debt to Total Assets (A: Jan. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Jan. 2025 )/Total Assets (A: Jan. 2025 )
=0.122/0.999
=

Gemina Laboratories's Long-Term Debt to Total Asset Ratio for the quarter that ended in Oct. 2025 is calculated as

LT Debt to Total Assets (Q: Oct. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Oct. 2025 )/Total Assets (Q: Oct. 2025 )
=0/0.794
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Gemina Laboratories (GLABF) has a LT-Debt-to-Total-Asset of 0.00 as of Oct. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' LT-Debt-to-Total-Asset too high?
Gemina Laboratories' current LT-Debt-to-Total-Asset is 0.00.
How does Gemina Laboratories' LT-Debt-to-Total-Asset compare to VRTX and REGN?
Gemina Laboratories' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Gemina Laboratories and its competitors. Gemina Laboratories's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current LT-Debt-to-Total-Asset is 0.00 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.